Intermediate soluble oligomers of Aβs, rather than the aggregated Aβs, are increasingly recognized as having cellular toxicity in AD (Kuo et al., 1996; Lansbury, 1999; Hardy and Selkoe, 2002; Lesne et al., 2006; Liu et al., 2015). This evidence concerns the gene DDX41 and Alzheimer disease.